Mediwound (MDWD)

Mediwound Stock Analysis & Ratings

MDWD Stock Chart & Stats

Day’s Range$1.72 - $1.84
52-Week Range$1.25 - $6.22
Previous Close$1.77
Average Volume (3M)119.93K
Market Cap$58.52M
P/E Ratio-3.6
Next EarningsAug 09, 2022
EPS ForecastN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score7
EPS (TTM)-0.50



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Mediwound’s price range in the past 12 months?
Mediwound lowest stock price was $1.25 and its highest was $6.22 in the past 12 months.
    What is Mediwound’s market cap?
    Mediwound’s market cap is $58.52M.
      What is Mediwound’s price target?
      The average price target for Mediwound is $4.75. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $6.50 ,the lowest forecast is $3.00. The average price target represents 163.89% Increase from the current price of $1.8.
        What do analysts say about Mediwound?
        Mediwound’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
          When is Mediwound’s upcoming earnings report date?
          Mediwound’s upcoming earnings report date is Aug 09, 2022 which is in 83 days.
            How were Mediwound’s earnings last quarter?
            Mediwound released its earnings results on May 17, 2022. The company reported -$0.12 earnings per share for the quarter, missing the consensus estimate of -$0.108 by -$0.012.
              Is Mediwound overvalued?
              According to Wall Street analysts Mediwound’s price is currently Undervalued.
                Does Mediwound pay dividends?
                Mediwound does not currently pay dividends.
                What is Mediwound’s EPS estimate?
                Mediwound’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Mediwound have?
                Mediwound has 32,460,000 shares outstanding.
                  What happened to Mediwound’s price movement after its last earnings report?
                  Mediwound reported an EPS of -$0.12 in its last earnings report, missing expectations of -$0.108. Following the earnings report the stock price went down -6.349%.
                    Which hedge fund is a major shareholder of Mediwound?
                    Among the largest hedge funds holding Mediwound’s share is ARK Investment Management LLC. It holds Mediwound’s shares valued at 4K.


                      Mediwound Stock Analysis

                      The Mediwound stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description


                      MediWound Ltd. is a biopharmaceutical company engaging in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product is NexoBrid. The company was founded by Lior Rosenberg and Marian Gorecki in 2001 and is headquartered in Yavne, Israel.

                      Similar Stocks
                      Price & Change
                      Smith & Nephew Snats

                      Popular Stocks

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis